MHRA approves donidalorsen (Dawnzera) for the treatment of hereditary angioedema
seen at 17:02, 7 May in News and communications.MHRA approves donidalorsen (Dawnzera) for the treatment of hereditary angioedema
seen at 17:02, 7 May in News and communications.